Literature DB >> 12748852

Megadose methylprednisolone for Kasabach-Merritt syndrome.

Şinasi Özsoylu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12748852     DOI： 10.1007/s00431-002-1142-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  High-dose intravenous methylprednisolone for pure red cell aplasia.

Authors:  S Ozsoylu
Journal:  Am J Hematol       Date:  1990-07       Impact factor: 10.047

2.  Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia.

Authors:  S Inceman; Y Tangũn
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

3.  High-dose oral methylprednisolone therapy in childhood hemangiomas.

Authors:  K M Uysal; N Olgun; A Erbay; F Sarialioğlu
Journal:  Pediatr Hematol Oncol       Date:  2001 Jul-Aug       Impact factor: 1.969

4.  Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review.

Authors:  Tanja Frevel; Heike Rabe; Frank Uckert; Erik Harms
Journal:  Eur J Pediatr       Date:  2002-03-26       Impact factor: 3.183

5.  High-dose intravenous corticosteroid for a patient with Diamond-Blackfan syndrome refractory to classical prednisone treatment.

Authors:  S Ozsoylu
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

6.  High dose intravenous methylprednisolone for Kassabach-Merritt syndrome.

Authors:  S Ozsoylu; G Irken; A Gürgey
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

7.  High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.

Authors:  J C Bernini; J M Carrillo; G R Buchanan
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.